Back to Atlas
BSemi-durableStandard research/education caution
CMP-0249
Investigational
Usmarapride Oxalate
Cholinergic / Nootropic
Procognitive signaling; may augment cholinergic tone and cognition
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- 5-HT4 receptor partial agonism
- Primary market use
- Alzheimer's cognition / schizophrenia cognition
Pharmacology
- Molecular weight (Da)
- Not established
- Oral bioavailability
- Unknown
- Half-life
- ~2–12 h small-molecule class estimate
- Route tags
- Route-dependent / verify
- Evidence level
- Preclinical/Phase I
- Clinical status
- Investigational
- Value-for-money score
- 4 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Classified B because cognitive adaptation may outlast acute receptor occupancy; still primarily experimental